Clinical trial

Anti-viral Therapy in Alzheimer's Disease

NCT03282916

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-02-12

PhasePHASE2

Study timeline

Study start (actual)2018-02-12Date precision: day

Registry last updated2025-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Herpes Simplex 1unresolved

Herpes Simplex 2unresolved

Interventions

ValacyclovirDRUG · verified · RxNorm: valacyclovir

Sponsors & collaborators

Columbia Universitylead sponsor

National Institutes of Health (NIH)collaborator

National Institute on Aging (NIA)collaborator

Mapped research locations

New YorkNew York, United States2 PhoenixArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03282916 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.